DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claims 1-7 are pending.
Specification
The disclosure is objected to because of the following informalities: in para. 0023, “dimethylformide” should be “dimethylformamide”.
Appropriate correction is required.
Claim Objections
Claim 4 is objected to because of the following informalities: “dimethylformide” should be “dimethylformamide”.
Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 1 (from which claims 2-7 depend) recites a weight percentage of three components, but does not state what larger quantity these weight percentages are a percentage of, for example, a carbon black solution of low shrinkage photocurable material.
Claim 4 (from which claim 5 depends) recites “a dimethylformide” twice. It is unclear whether the dimethylformide (dimethylformamide) in the steps is the same. The office recommends reciting a first and second amount of dimethylformamide for the two steps.
Allowable Subject Matter
Claims 1-7 would be allowable if rewritten or amended to overcome the objections and rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action.
The following is a statement of reasons for the indication of allowable subject matter: Lin (US 4,537,805) teaches compositions of acrylonitrile butadiene styrene resin (ABS), with reactive plasticizer (which may be considered a dispersant), which reactive plasticizer may be photocurable, thus a photocurable composition. Lin also teaches carbon black may be incorporated, but does not provide rationale to arrive at the recited method of addition and amounts therein (presuming the weight percentages are of the low-shrinkage photocurable material). While the addition of carbon black to ABS is known, for example, Chiao (US 4,243,577), the art does not provide sufficient rationale to arrive at the addition method and weight percentages as recited; moreover, such art is not assumed to be photocurable, since ABS is not generally considered a photocurable material. There exists “ABS-like” resins that are photocurable, see Leyden (US 2011/0293891), but the art suggests these are combination of photocurable epoxy and/or acrylate materials, and do not include ABS.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KREGG T BROOKS whose telephone number is (313)446-4888. The examiner can normally be reached Monday to Friday 9 am to 5:30 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Reuther can be reached at (571)270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KREGG T BROOKS/Primary Examiner, Art Unit 1764
Prosecution Insights